Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus

Journal of Antimicrobial Chemotherapy

Volumn 47, Issue 6, 2001, Pages 819-827

  Rossi, Luigia ^a   Serafini, Sonja ^a   Cappellacci, Loredana ^b   Balestra, Emanuela ^c   Brandi, Giorgio ^a   Schiavano, Giuditta F ^a   Franchetti, Palmarisa ^b   Grifantini, Mario ^b   Perno, Carlo Federico ^c,d   Magnani, Mauro ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; HOMODINUCLEOTIDE; HYPOTONIC SOLUTION; ISOTONIC SOLUTION; NUCLEOTIDE DERIVATIVE; PHOSPHATE; PRODRUG; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL COMPARTMENTALIZATION; CHEMICAL MODIFICATION; CONTROLLED STUDY; DIALYSIS; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ENCAPSULATION; ERYTHROCYTE; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY; MACROPHAGE; MOLECULAR RECOGNITION; MONOCYTE; PATHOGENESIS; PHAGOCYTOSIS;

EID: 0034986978     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/47.6.819     Document Type: Article

References (36)

1. Immunology of HIV infection
2. The role of mononuclear phagocytes in HTLV-III/LAV infection
3. Infection of monocyte/macrophages by human T lymphotropic virus type III
4. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain
5. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy
6. Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease
7. Full-length recombinant CD4 and recombinant gp120 inhibit fusion between HIV infected macrophages and uninfected CD4-expressing T-lymphoblastoid cells
8. Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes
9. Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV
10. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages
11. Herpes simplex virus type 1 replication and IL-1 beta gene expression in mouse peritoneal macrophages activated in vivo by an attenuated Salmonella typhimurium vaccine or Corynebacterium parvum
12. Comparative immunohistochemical study of herpes simplex and varicella zoster infections
13. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow
14. Activation of human immunodeficiency virus by herpes simplex virus
15. Herpes simplex virus type 1-mediated induction of human immunodeficiency virus type 1 provirus correlates with binding of nuclear proteins to the NF-kappa B enhancer and leader sequence
16. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1
17. A randomized, double-blind, placebo-controlled phase I/II evaluation of 9-[2-(bispivaloyloxymethyl)phosphonylmethoxy]adenine (Bis-POM PMEA), an orally bioavailable prodrug of the anti-HIV nucleotide, PMEA
18. Marked in vivo antiretrovirus 9-(2-phosphonylmethoxyethyl)adenine, a selective anti human immunodeficiency virus agent
19. 9-(2-phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replications in vitro and simian immunodeficiency virus infection in rhesus monkeys
20. Single-dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the prophylaxis of retrovirus infection in vivo
21. 9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections
22. Antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in vivo increases when it is less frequently administered
23. Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo
24. Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: In vitro and in vivo studies
25. Inhibition of murine retrovirus-induced immunodeficiency disease by dideoxycytidine and dideoxycytidine 5′-triphosphate
26. Feline immunodeficiency virus infection of macrophages: In vitro and in vivo inhibition by dideoxycytidine 5′-triphosphate-loaded erythrocytes
27. Red blood cell mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: Efficiency, metabolism and activity against human immunodeficiency virus or herpes simplex virus
28. Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection
29. Macrophage protection against human immunodeficiency virus or herpes simplex virus by red blood cell-mediated delivery of a heterodinucleotide azidothymidine and acyclovir
30. Reversed-phase liquid chromatographic determination of 2′,3′-dideoxycytidine in human blood samples
31. Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl) adenine (PMEA) in primary macrophages is determined by drug metabolism, nucleotide pools and cytokines
32. Free ADP-ribose in human erythrocytes: Pathways of intra-erythrocytic conversion and non-enzymic binding to membrane proteins
33. Phagocytosis reduces HIV-1 production in human monocyte/macrophages infected in vitro
34. Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound
35. 5-Phosphoribosyl-1-pyrophosphate synthetase converts the acyclic nucleoside phosphonates 9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 9-(2-phosphonylmethoxyethyl)adenine directly to their antivirally derivatives
36. Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp 120 protein in human monocytes/macrophages